PMID- 23817697 OWN - NLM STAT- MEDLINE DCOM- 20131031 LR - 20211021 IS - 1432-1335 (Electronic) IS - 0171-5216 (Linking) VI - 139 IP - 9 DP - 2013 Sep TI - Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. PG - 1499-506 LID - 10.1007/s00432-013-1469-2 [doi] AB - PURPOSE: Altered microRNA (miRNA) expression has been found in many cancers, including lung, breast, prostate, bladder and colorectal cancer. Many recent studies have demonstrated that aberrant plasma miRNAs were also found in various types of cancers. However, the alteration in plasma miRNA expressions in laryngeal squamous cell carcinoma (LSCC) remains unclear. The present study aimed to investigate the alterations in plasma miRNAs in LSCC. METHODS: In the present study, the expression profiles of 738 miRNAs in plasma from 20 patients and 44 healthy subjects were evaluated using high-throughput real-time quantitative polymerase chain reaction. RESULTS: Our results demonstrated that expression levels of 17 miRNAs were significantly upregulated in patients with LSCCs when compared to control group (p < 0.05). Expression levels of nine miRNAs were found significantly downregulated in LSCC patients (p < 0.05). In addition, 17 miRNAs were expressed only in LSCC group, and five of these miRNAs (miR-331-3p, 603, 1303, 660-5p and 212-3p) are LSCC specific and never seen before in plasma of any human subject. CONCLUSION: In conclusion, our study suggests that detecting these LSCC-specific miRNAs in plasma might serve as novel noninvasive biomarkers for LSCC. FAU - Ayaz, Lokman AU - Ayaz L AD - Department of Biochemistry, Faculty of Pharmacy, Trakya University, Edirne, 22030, Turkey. lokmanayaz@yahoo.com FAU - Gorur, Aysegul AU - Gorur A FAU - Yaroglu, Hatice Yildirim AU - Yaroglu HY FAU - Ozcan, Cengiz AU - Ozcan C FAU - Tamer, Lulufer AU - Tamer L LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130702 PL - Germany TA - J Cancer Res Clin Oncol JT - Journal of cancer research and clinical oncology JID - 7902060 RN - 0 (Biomarkers, Tumor) RN - 0 (MicroRNAs) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Biomarkers, Tumor/blood/*genetics MH - Carcinoma, Squamous Cell/blood/diagnosis/*genetics MH - Case-Control Studies MH - Early Diagnosis MH - Female MH - Gene Expression Profiling MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Laryngeal Neoplasms/blood/diagnosis/*genetics MH - Male MH - MicroRNAs/*genetics MH - Middle Aged MH - Neoplasm Staging MH - Oligonucleotide Array Sequence Analysis MH - Prognosis MH - Real-Time Polymerase Chain Reaction MH - Reverse Transcriptase Polymerase Chain Reaction MH - Young Adult EDAT- 2013/07/03 06:00 MHDA- 2013/11/01 06:00 CRDT- 2013/07/03 06:00 PHST- 2013/05/01 00:00 [received] PHST- 2013/06/20 00:00 [accepted] PHST- 2013/07/03 06:00 [entrez] PHST- 2013/07/03 06:00 [pubmed] PHST- 2013/11/01 06:00 [medline] AID - 10.1007/s00432-013-1469-2 [doi] PST - ppublish SO - J Cancer Res Clin Oncol. 2013 Sep;139(9):1499-506. doi: 10.1007/s00432-013-1469-2. Epub 2013 Jul 2.